bioRxiv · 10.1101/2024.03.27.583257
Circular RNA aptamers ameliorate AD-relevant phenotypes by targeting PKR
Abstract
Here, we delineated the remarkably elevated neuroinflammation accompanied by progressive activation of double-stranded RNA (dsRNA)-activated Protein Kinase R (PKR) and PKR-related dsRNA pathways in hippocampus of 5xFAD mice upon Alzheimers disease (AD) progression. AAV-delivery of circular RNAs possessing short-imperfect duplex regions (ds-cRNAs) to neurons and microglia effectively dampened excessive PKR activity with little toxicity, accompanying with reduced neuroinflammation and amyloid-beta (A{beta}) plaques, resulting in neuroprotection and enhanced capability of spatial learning and memory in AD mouse models. These findings suggest a therapeutic potential of ds-cRNA aptamers as PKR inhibitors in AD therapy.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Feng, X., Jiang, B.-W., Zhai, S.-N., Liu, C.-X., Wu, H., Zhu, B.-Q., Wei, M.-Y., Wei, J., Yang, L., Chen, L.-L.. 2024-03-27. Circular RNA aptamers ameliorate AD-relevant phenotypes by targeting PKR. https://doi.org/10.1101/2024.03.27.583257
Cite the original work for its findings. Save a collection to share your selection of sources.